{"name": "Nautilus Biotech",
 "permalink": "nautilus-biotech",
 "crunchbase_url": "http://www.crunchbase.com/company/nautilus-biotech",
 "homepage_url": "",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 1999,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "33-1-60-87-54-60",
 "description": "",
 "created_at": "Mon Mar 15 04:20:52 UTC 2010",
 "updated_at": "Sat Jul 03 11:25:46 UTC 2010",
 "overview": "\u003Cp\u003ENautilus Biotech is a biotechnology company. The company has a pipeline of therapeutic proteins with improved profiles. The company\u00e2\u20ac\u2122s products include Belerofon, an injectable and orally available interferon alpha for use in the treatment of chronic Hepatitis C infection; and Vitatropin, an injectable and orally available human growth hormone (hGH) for use in the treatment of growth deficiencies. Nautilus Biotech S.A. sells therapeutic proteins, including interferons, hormones, growth factors, and enzymes in France and internationally. The company\u0026#8217;s protein engineering technology improves the pharmacology profile and administration route of blockbuster protein drugs. Nautilus Biotech S.A. was founded in 1999 and is based in Evry, France.\u003C/p\u003E",
 "image": null,
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$18.6M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.prnewswire.com/news-releases/nautilus-biotech-closes-eur84-million-113-million-investment-funding-58859082.html",
    "source_description": "Nautilus Biotech Closes EUR8.4 Million ($11.3 Million) Investment Funding",
    "raised_amount": 11300000.0,
    "raised_currency_code": "USD",
    "funded_year": 2007,
    "funded_month": 4,
    "funded_day": 30,
    "investments":
     [{"company":
        {"name": "Creabilis",
         "permalink": "creabilis",
         "image":
          {"available_sizes":
            [[[123,
               104],
              "assets/images/resized/0008/0329/80329v2-max-150x150.png"],
             [[123,
               104],
              "assets/images/resized/0008/0329/80329v2-max-250x250.png"],
             [[123,
               104],
              "assets/images/resized/0008/0329/80329v2-max-450x450.png"]],
           "attribution": null}},
       "financial_org": null,
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Rothschild Gestion",
         "permalink": "rothschild-gestion",
         "image":
          {"available_sizes":
            [[[150,
               22],
              "assets/images/resized/0002/9376/29376v1-max-150x150.png"],
             [[222,
               33],
              "assets/images/resized/0002/9376/29376v1-max-250x250.png"],
             [[222,
               33],
              "assets/images/resized/0002/9376/29376v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Auriga Partners",
         "permalink": "auriga-partners",
         "image":
          {"available_sizes":
            [[[150,
               104],
              "assets/images/resized/0003/9844/39844v2-max-150x150.png"],
             [[250,
               173],
              "assets/images/resized/0003/9844/39844v2-max-250x250.png"],
             [[335,
               233],
              "assets/images/resized/0003/9844/39844v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Matignon Investissement \u0026 Gestion",
         "permalink": "matignon-investissement-gestion",
         "image":
          {"available_sizes":
            [[[150,
               56],
              "assets/images/resized/0008/0331/80331v1-max-150x150.jpg"],
             [[250,
               95],
              "assets/images/resized/0008/0331/80331v1-max-250x250.jpg"],
             [[300,
               114],
              "assets/images/resized/0008/0331/80331v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "123Venture",
         "permalink": "123venture",
         "image":
          {"available_sizes":
            [[[150,
               45],
              "assets/images/resized/0002/9739/29739v2-max-150x150.png"],
             [[208,
               63],
              "assets/images/resized/0002/9739/29739v2-max-250x250.png"],
             [[208,
               63],
              "assets/images/resized/0002/9739/29739v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "unattributed",
    "source_url": "http://www.fdanews.com/newsletter/article?issueId=7268\u0026articleId=69367",
    "source_description": "Completion of Euros 7.25 Million Round of Financing in Nautilus",
    "raised_amount": 7250000.0,
    "raised_currency_code": "EUR",
    "funded_year": 2005,
    "funded_month": 3,
    "funded_day": 3,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Auriga Partners",
         "permalink": "auriga-partners",
         "image":
          {"available_sizes":
            [[[150,
               104],
              "assets/images/resized/0003/9844/39844v2-max-150x150.png"],
             [[250,
               173],
              "assets/images/resized/0003/9844/39844v2-max-250x250.png"],
             [[335,
               233],
              "assets/images/resized/0003/9844/39844v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Matignon Investissement \u0026 Gestion",
         "permalink": "matignon-investissement-gestion",
         "image":
          {"available_sizes":
            [[[150,
               56],
              "assets/images/resized/0008/0331/80331v1-max-150x150.jpg"],
             [[250,
               95],
              "assets/images/resized/0008/0331/80331v1-max-250x250.jpg"],
             [[300,
               114],
              "assets/images/resized/0008/0331/80331v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Edmond de Rothschild Venture Capital",
         "permalink": "edmond-de-rothschild-venture-capital",
         "image":
          {"available_sizes":
            [[[150,
               50],
              "assets/images/resized/0001/6998/16998v7-max-150x150.png"],
             [[250,
               83],
              "assets/images/resized/0001/6998/16998v7-max-250x250.png"],
             [[292,
               98],
              "assets/images/resized/0001/6998/16998v7-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "123Venture",
         "permalink": "123venture",
         "image":
          {"available_sizes":
            [[[150,
               45],
              "assets/images/resized/0002/9739/29739v2-max-150x150.png"],
             [[208,
               63],
              "assets/images/resized/0002/9739/29739v2-max-250x250.png"],
             [[208,
               63],
              "assets/images/resized/0002/9739/29739v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "1, rue Pierre Fontaine",
    "address2": "Evry,  91000",
    "zip_code": "",
    "city": "",
    "state_code": null,
    "country_code": "FRA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}